M. Kramer, and A. Feinstein. Clinical pharmacology and therapeutics, 29 (1):
111-23(January 1981)2975<m:linebreak></m:linebreak>Mesures de concordància.
H. Putter, M. Fiocco, and R. Geskus. Statistics in medicine, 26 (11):
2389-430(May 2007)4686<m:linebreak></m:linebreak>CI: Copyright 2006; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
B. Giraudeau, and J. Mary. Statistics in medicine, 20 (21):
3205-14(November 2001)5343<m:linebreak></m:linebreak>LR: 20071115; CI: Copyright 2001; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Sample size; Mesures de concordància.
Y. Chen, C. Hu, and Y. Wang. Biostatistics (Oxford, England), 7 (4):
515-29(October 2006)5077<m:linebreak></m:linebreak>JID: 100897327; 2006/02/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
N. Dendukuri, E. Rahme, P. Bélisle, and L. Joseph. Biometrics, 60 (2):
388-97(June 2004)5555<m:linebreak></m:linebreak>JID: 0370625; ppublish;<m:linebreak></m:linebreak>Proves diagnòstiques; Sample size.